Gene · 11343
Papers2,780
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,780
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synergistic effect and mechanism of monoacylglycerol lipase inhibitor and Icaritin in the treatment of ulcerative colitis. | Int Immunopharmacol | 2024 | 39276456 | PubTator, text mining | PubMed |
| The Endocannabinoid System in Alzheimer's Disease: A Network Meta-Analysis. | J Neurosci Res | 2024 | 39245959 | PubTator, text mining | PubMed |
| Enhancing Drug Discovery and Development through the Integration of Medicinal Chemistry, Chemical Biology, and Academia-Industry Partnerships: Insights from Roche's Endocannabinoid System Projects. | Chimia (Aarau) | 2024 | 39221845 | PubTator, text mining | PubMed |
| The role of monoglyceride lipase gene in promoting proliferation, metastasis, and free fatty acid accumulation in uveal melanoma cells. | Hum Cell | 2024 | 39181971 | PubTator, text mining | PubMed |
| Monoacylglycerol lipase blockades the senescence-associated secretory phenotype by interfering with NF-κB activation and promotes docetaxel efficacy in prostate cancer. | Oncogene | 2024 | 39155296 | PubTator, text mining | PubMed |
| Lipases are differentially regulated by hormones to maintain free fatty acid homeostasis for insect brain development. | BMC Biol | 2024 | 39135168 | PubTator, text mining | PubMed |
| Endocannabinoids regulate enteric neuron-glia networks and visceral hypersensitivity following inflammation through a glial-dependent mechanism. | Glia | 2024 | 39132860 | PubTator, text mining | PubMed |
| Genetic Factors Contributing to Interindividual Variability of α-Tocopherol Levels in Subcutaneous Adipose Tissue among Healthy Adult Males. | Nutrients | 2024 | 39125437 | PubTator, text mining | PubMed |
| Design, synthesis and biological evaluation of naphthyl amide derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors. | Bioorg Med Chem | 2024 | 39106652 | PubTator, text mining | PubMed |
| Fluorescence-Based Enzyme Activity Assay: Ascertaining the Activity and Inhibition of Endocannabinoid Hydrolytic Enzymes. | Int J Mol Sci | 2024 | 39062935 | PubTator, text mining | PubMed |
| Novel Heterocyclic Compounds as Monoacylglycerol Lipase Inhibitors for Treating Multiple Diseases. | ACS Med Chem Lett | 2024 | 39015277 | PubTator, text mining | PubMed |
| Inhibition of 2-AG hydrolysis alleviates posttraumatic headache attributed to mild traumatic brain injury. | J Headache Pain | 2024 | 39014318 | PubTator, text mining | PubMed |
| Structure-Activity Relationship Studies of Aryl Sulfoxides as Reversible Monoacylglycerol Lipase Inhibitors. | J Med Chem | 2024 | 38988250 | PubTator, text mining | PubMed |
| A carrier free delivery system of a MAGL inhibitor is effective on ovarian cancer. | Eur J Pharm Biopharm | 2024 | 38972466 | PubTator, text mining | PubMed |
| Microplastics Biodegradation by Estuarine and Landfill Microbiomes. | Microb Ecol | 2024 | 38943017 | PubTator, text mining | PubMed |
| Disrupted stress-induced analgesia in a neuropathic pain state is rescued by the endocannabinoid degradation inhibitor JZL195. | J Neurochem | 2024 | 38922705 | PubTator, text mining | PubMed |
| Endocannabinoid Hydrolase Inhibitors: Potential Novel Anxiolytic Drugs. | Drug Des Devel Ther | 2024 | 38882045 | PubTator, text mining | PubMed |
| Watermelon: setup and validation of an in silico fragment-based approach. | J Enzyme Inhib Med Chem | 2024 | 38864179 | PubTator, text mining | PubMed |
| Reversal of tamoxifen resistance by artemisinin in ER+ breast cancer: bioinformatics analysis and experimental validation. | Oncol Res | 2024 | 38827320 | PubTator, text mining | PubMed |
| Integrative multi-omics analysis reveals ortho-topolin riboside exhibits anticancer activity by regulating metabolic pathways in radio-resistant triple negative breast cancer cells. | Chem Biol Interact | 2024 | 38823535 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11343/papers?page=9